
- Sun, 1 March 2026
A Seed Round To Accelerate Carbon Innovation
Intrinsic Foundries has secured Rs 12 crore in seed funding in a round led by Transition VC. The capital will support industrial pilot execution, research expansion, and intellectual property filings.
The company also plans to scale its engineering and commercial teams, strengthen manufacturing capabilities, and establish a United States entity to drive global market development.
Reimagining Carbon As A Resource
Founded in 2023 by Shreyansh Jain, Sanjay Jain, and Umang Jain, Intrinsic Foundries is building a carbon to value biomanufacturing platform.
The startup captures industrial emissions, effluents, and residues and converts them into premium biochemicals. Its technology stack includes proprietary microbial biorefinery systems, modular photobioreactors, and integrated automation.
The goal is clear. Enable scalable and revenue positive decarbonization while supplying sustainable ingredients to global industries.
Solving The Economics Of Carbon Capture
Carbon Capture Utilisation and Storage has long faced adoption challenges due to capital intensity and weak unit economics.
Intrinsic Foundries approaches the problem differently. It captures CO2 using microalgae in upstream processes and converts the captured carbon into high value biochemical outputs. These outputs serve pharmaceutical, nutraceutical, and cosmetic industries.
By generating revenue from carbon conversion, the company aims to make carbon capture commercially viable rather than purely compliance driven.
Strategic Global Collaborations
The startup maintains research and development partnerships in the United States and Germany. It brings together process engineers, scientists, and automation specialists at the intersection of industrial biotechnology and biomanufacturing.
This international collaboration is expected to strengthen its technical depth as it scales pilots and commercial operations.
The Road Ahead
Over the next 12 to 24 months, Intrinsic Foundries plans to commission multiple industrial pilots and operationalise its first one ton per day commercial plant.
It also aims to expand its patent portfolio, generate cumulative revenues from pilot projects and biochemical products, and deepen international market access.
In the long term, the company seeks to build carbon to value biomanufacturing infrastructure as a foundational layer for global industrial decarbonization.




contact@GrowthSenseNews.com
Sign up to get exciting updates through our newsletter- your one-stop for all things startup!